| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.065 | 0.2 |